Celyad Oncology SA
SWB:1C0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celyad Oncology SA
SWB:1C0
|
BE |
|
R
|
Region Re Ltd
F:S590
|
AU |
|
B
|
Bank Negara Indonesia (Persero) Tbk PT
XMUN:BKE1
|
ID |
|
S
|
Sinopec Oilfield Service Corp
HKEX:1033
|
CN |
|
L
|
Liveramp Holdings Inc
SWB:XIM
|
US |
|
E
|
Enwave Corp
XBER:E4U
|
CA |
|
S
|
SolGold PLC
XBER:S8F
|
AU |
|
S
|
Suncor Energy Inc
XBER:SM3
|
CA |
|
A
|
Ameresco Inc
SWB:4AM
|
US |
|
L
|
Link Real Estate Investment Trust
SWB:L5R
|
HK |
|
B
|
BayWa AG
DUS:BYW
|
DE |
|
C
|
China Resources Power Holdings Co Ltd
XBER:CRP
|
HK |
Shareholder Yield
Current shareholder yield for 
1C0 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
1C0 Price
Celyad Oncology SA
| Average Annual Return | -11.89% |
| Standard Deviation of Annual Returns | 74.09% |
| Max Drawdown | -98% |
| Market Capitalization | 12.9m EUR |
| Shares Outstanding | 193 688 886 |
| Percentage of Shares Shorted |
N/A
|
